Daniel Chancellor
VP, Thought Leadership at Norstella
Biopharma industry advisor with ~15 years of experience spanning drug discovery, market analysis, competitive intelligence, and strategic consulting. Currently delivering and overseeing thought leadership activities for Citeline and Evaluate, using proprietary, gold-standard datasets to communicate the opportunities and challenges facing the industry today. Regular contributor to Scrip and In Vivo newsletters, external commentator for leading business publications, including the WSJ, Reuters and The Economist, plus a frequent speaker and presenter at partnering conferences across the US, Europe and Japan.
Contributing Author
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
